Comments
Loading...

Health Catalyst

HCATNASDAQ
Logo brought to you by Benzinga Data
$8.35
0.11.21%
At close: -
$8.35
0.000.00%
After Hours: Dec 6, 4:00 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$28.00
Lowest Price Target1
$9.00
Consensus Price Target1
$14.34

Health Catalyst (NASDAQ:HCAT) Stock, Analyst Ratings, Price Targets, Forecasts

Health Catalyst Inc has a consensus price target of $14.34 based on the ratings of 18 analysts. The high is $28 issued by Jefferies on March 17, 2022. The low is $9 issued by Stephens & Co. on November 14, 2024. The 3 most-recent analyst ratings were released by Piper Sandler, Stephens & Co., and Citigroup on November 26, 2024, November 14, 2024, and November 13, 2024, respectively. With an average price target of $10.5 between Piper Sandler, Stephens & Co., and Citigroup, there's an implied 25.75% upside for Health Catalyst Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jul
3
1
Aug
2
Sep
2
Oct
2
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Piper Sandler
Stephens & Co.
Citigroup
RBC Capital
Evercore ISI Group

1calculated from analyst ratings

Analyst Ratings for Health Catalyst

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Health Catalyst (HCAT) stock?

A

The latest price target for Health Catalyst (NASDAQ:HCAT) was reported by Piper Sandler on November 26, 2024. The analyst firm set a price target for $12.00 expecting HCAT to rise to within 12 months (a possible 43.71% upside). 27 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Health Catalyst (HCAT)?

A

The latest analyst rating for Health Catalyst (NASDAQ:HCAT) was provided by Piper Sandler, and Health Catalyst reiterated their overweight rating.

Q

When was the last upgrade for Health Catalyst (HCAT)?

A

The last upgrade for Health Catalyst Inc happened on January 26, 2024 when Guggenheim raised their price target to $14. Guggenheim previously had a neutral for Health Catalyst Inc.

Q

When was the last downgrade for Health Catalyst (HCAT)?

A

The last downgrade for Health Catalyst Inc happened on April 10, 2024 when Keybanc changed their price target from N/A to N/A for Health Catalyst Inc.

Q

When is the next analyst rating going to be posted or updated for Health Catalyst (HCAT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Health Catalyst, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Health Catalyst was filed on November 26, 2024 so you should expect the next rating to be made available sometime around November 26, 2025.

Q

Is the Analyst Rating Health Catalyst (HCAT) correct?

A

While ratings are subjective and will change, the latest Health Catalyst (HCAT) rating was a reiterated with a price target of $11.00 to $12.00. The current price Health Catalyst (HCAT) is trading at is $8.35, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch